Related Experiment Video
Updated: May 2, 2026
06:52
Positron Emission Tomography Using 64-Copper as a Tracer for the Study of Copper-Related Disorders
Published on: April 28, 2023
2.3K
Relation between copper, lipid profile, and cognition in elderly Jordanians
Eman Al-khateeb1, Ebaa Al-zayadneh1, Osama Al-dalahmah2
1Department of Physiology & Biochemistry, University of Jordan, Amman, Jordan.
Journal of Alzheimer'S Disease : JAD
|March 4, 2014
Summary
Serum copper and lipid levels did not significantly correlate with cognitive decline in elderly Jordanians. However, lower education and increased coffee intake were associated with dementia risk.
Area of Science:
- Neuroscience
- Biochemistry
- Gerontology
Background:
- Cognitive decline and dementia are significant health concerns in aging populations.
- Biochemical markers like serum copper and lipid profiles are being investigated for their role in cognitive health.
- Understanding risk factors is crucial for developing preventative strategies for dementia.
Purpose of the Study:
- To investigate the association between serum copper and lipid concentrations and cognitive function changes in elderly Jordanians.
- To identify demographic and lifestyle factors influencing dementia risk in this population.
Main Methods:
- Cross-sectional study comparing 52 dementia patients and 50 control subjects.
- Cognitive function assessed using Mini-Mental State Examination and Clock Drawing Test.
- Serum copper and lipid profiles analyzed, with statistical evaluation at p < 0.05.
Main Results:
- No statistically significant differences in serum copper or lipid profiles between dementia patients and controls.
- No significant correlation found between serum copper, lipid profile, and cognitive decline.
- Lower educational attainment (less than 12 years, illiterate) significantly increased dementia risk (3.29-fold and 6.29-fold, respectively).
- Increased coffee intake showed a protective effect, reducing dementia risk by 6.25-fold.
Conclusions:
- Serum copper and lipid profiles are not significant predictors of cognitive decline in elderly Jordanians.
- Educational level and coffee consumption are important modifiable factors influencing dementia risk in this population.
- Further research is needed to explore other potential biomarkers and protective factors for cognitive health in aging individuals.
Related Concept Videos
01:30Cognitive Development During Adulthood
1.4K
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.4K
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
400
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
400
01:15Drug Dosing: Geriatric Patients
395
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
395
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
367
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
367
01:22Dementia l: Introduction
35
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
382
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
382